TrialBlood cancer discovery2025

High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Yan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.